Last reviewed · How we verify
APSTZD 1
APSTZD 1 is an investigational drug with unknown mechanism of action.
At a glance
| Generic name | APSTZD 1 |
|---|---|
| Sponsor | Apsen Farmaceutica S.A. |
| Modality | Small molecule |
| Phase | Phase 2 |
Mechanism of action
Further research is needed to determine the exact mechanism of action of APSTZD 1.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |